Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections

Omicron variants of SARS-CoV-2 have been become the dominant variant family among more than 100 countries and regions around the world. There are still limited data on how inactivated COVID-19 vaccines prevent Omicron-related symptomatic infection, transmission, hospital admission, and death3. Recen...

Full description

Saved in:
Bibliographic Details
Published inClinical ehealth Vol. 6; pp. 1 - 2
Main Author Chen, Yifan
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.12.2023
The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd
KeAi Communications Co., Ltd
Subjects
COVID-19
Editorials
Epidemiology
Omicron
Public health
Vaccine
COVID-19
Editorials
Vaccine
Omicron
Epidemiology
Public health
Online AccessGet full text

Cover

More Information
Summary:Omicron variants of SARS-CoV-2 have been become the dominant variant family among more than 100 countries and regions around the world. There are still limited data on how inactivated COVID-19 vaccines prevent Omicron-related symptomatic infection, transmission, hospital admission, and death3. Recently, Dawei Yang et al. published a paper in the to explore the effect of inactivated COVID-19 vaccines on Omicron from the perspective of real-world observation data.
ISSN:2588-9141
2588-9141
DOI:10.1016/j.ceh.2023.04.001